Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Collagen-based biodegradable matrices for localized drug delivery More
A novel non-invasive method for using carbon-13 magnetization transfer effects to determine and evaluate in vivo aspartate transaminase (AST) activity and levels in an organ, as a biomarker of disease and certain neurological disorders. More
Lotuzol is a new herbal drug composing water extract powder of Nelumbinis Semen to treat depression without sexual dysfunction, a major adverse effect in commonly used anti-depressants. More
Biomarker and possible therapeutic target for a variety of neurodegenerative diseases More
Methods and formulations for treating or preventing Vascular Cognitive Impairment (VCI) through mucosal administration of E-selectin, an inducible adhesion molecule on endothelial cells More
Cancer immunotherapy using dendritic cells, and iii) Camel recombinant antibodies for FoxP3, Mucl & CEA. More
A method to promote stem cell survival and proliferation by manipulating the phosphorylation state, a key protein in these processes More
Assay should predict susceptibility to schizophrenia even before clinical symptoms are apparent, if aberrant ErbB function during development is a cause of schizophrenia and that function is expressed in peripheral blood cells throughout life. More
A method and composition for inhibiting or treating symptoms of inflammatory demyelination or inflammation associated with autoimmune disorders. More
Heart failure is associated with cardiac hypertropy, atheiosclerosis, myocardial infarction, valvular heart disease and hypertension. Many researches has focused on development of cardiotonics for treating heart failure. More
Related Reports
Market Research Reports provided by reports.innovaro.com
Jun 2006 - 1068 pages - $2,495
Oct 2010 - 53 pages - $1,000
Sep 2011 - 97 pages - $3,500
Jan 2010 - $75
Feb 2011 - 75 pages - $1,000
Dec 2008 - 50 pages - $400
May 2011 - 25 pages - $250
Mar 2011 - 6 pages - $500
Jan 2010 - $75
Nov 2007 - 173 pages - $1,860
Your selection
Browse By
- Industry sector
- Assay systems
- Diagnostic test systems
- Gene therapy
- Human diagnostics
- Human therapeutics
- Nanotechnology
- Other
- Research supplies
- Stem cells
- Therapeutic target
- Age-related disorders (other)
- Amyotrophic lateral sclerosis
- CNS (other)
- Neurodegenerative disorders
- Neurological
- Pain
- Psychiatric
- Subarachnoid hemorrhage
- Traumatic brain injury
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2012 Innovaro Europe Ltd 
All rights reserved. Terms and Conditions | Contact us